Literature DB >> 3124801

Iontophoresis of tobramycin for the treatment of experimental Pseudomonas keratitis in the rabbit.

D S Rootman1, J A Hobden, J A Jantzen, J R Gonzalez, R J O'Callaghan, J M Hill.   

Abstract

Iontophoresis of tobramycin sulfate was employed to treat bacterial keratitis induced in rabbits by an intrastromal injection of Pseudomonas aeruginosa. Quantitation of bacterial killing was achieved by culturing corneal homogenates and counting viable bacteria per cornea after treatment. When the rabbits received two iontophoretic treatments, iontophoresis significantly reduced the number of bacterial colony-forming units, compared with the use of an eyecup without current or two subconjunctival injections of 20 mg of tobramycin sulfate, and with untreated controls. The results of iontophoresis were not significantly different from those involving treatment with topical fortified drops (40 mg/mL). A single iontophoresis treatment was compared with the use of an eyecup without current or less fortified topical drops (13.6 mg/mL), as well as with untreated controls. Iontophoresis was significantly better than either the eyecup or the topical fortified tobramycin drops in reducing viable bacteria in the corneas. Iontophoresis may be a useful adjunct in the treatment of severe corneal bacterial infections.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3124801     DOI: 10.1001/archopht.1988.01060130276043

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  7 in total

Review 1.  New techniques for drug delivery to the posterior eye segment.

Authors:  Esther Eljarrat-Binstock; Jacob Pe'er; Abraham J Domb
Journal:  Pharm Res       Date:  2010-02-13       Impact factor: 4.200

2.  Efficacy of iontophoresis in the rat cornea.

Authors:  J Frucht-Pery; A Solomon; R Doron; P Ever-Hadani; O Manor; M Shapiro
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-12       Impact factor: 3.117

3.  The effect of iodide iontophoresis on the antioxidative capacity of the tear fluid.

Authors:  Gebhard Rieger; Manfred Klieber; Wolfgang Schimetta; Werner Pölz; Sirid Griebenow; Rudolf Winkler; Jutta Horwath-Winter; Otto Schmut; Birgit Spitzer-Sonnleitner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-05-23       Impact factor: 3.117

4.  Age and therapeutic outcome of experimental Pseudomonas aeruginosa keratitis treated with ciprofloxacin, prednisolone, and flurbiprofen.

Authors:  J A Hobden; J M Hill; L S Engel; R J O'Callaghan
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

5.  Iontophoretic application of tobramycin to uninfected and Pseudomonas aeruginosa-infected rabbit corneas.

Authors:  J A Hobden; D S Rootman; R J O'Callaghan; J M Hill
Journal:  Antimicrob Agents Chemother       Date:  1988-07       Impact factor: 5.191

Review 6.  Pharmacokinetic considerations in the treatment of bacterial keratitis.

Authors:  M C Callegan; R J O'Callaghan; J M Hill
Journal:  Clin Pharmacokinet       Date:  1994-08       Impact factor: 6.447

7.  Design of Topical Ocular Ciprofloxacin Nanoemulsion for the Management of Bacterial Keratitis.

Authors:  Ahmed Adel Ali Youssef; Chuntian Cai; Narendar Dudhipala; Soumyajit Majumdar
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.